Literature DB >> 18697746

Sulfation of the galactose residues in the glycosaminoglycan-protein linkage region by recombinant human chondroitin 6-O-sulfotransferase-1.

Hiroshi Kitagawa1, Kae Tsutsumi, Akemi Ikegami-Kuzuhara, Satomi Nadanaka, Fumitaka Goto, Tomoya Ogawa, Kazuyuki Sugahara.   

Abstract

6-O-Sulfated galactose residues have been demonstrated in the glycosaminoglycan-protein linkage region GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser isolated from shark cartilage chondroitin 6-sulfate (Sugahara, K., Ohi, Y., Harada, T., de Waard, P., and Vliegenthart, J. F. G. (1992) J. Biol. Chem. 267, 6027-6035). In this study, we investigated whether a recombinant human chondroitin 6-sulfotransferase-1 (C6ST-1) catalyzes the sulfation of C6 on both galactose residues in the linkage region using structurally defined acceptor substrates. The C6ST-1 was expressed as a soluble protein A chimeric form in COS-1 cells and purified using IgG-Sepharose. The purified C6ST-1 utilized the linkage tri-, tetra-, penta-, and hexasaccharide-serines and hexasaccharide alditols, including GlcUAbeta1-3GalNAc(4-O-sulfate)beta1-4GlcUAbeta1-3Gal(4-O-sulfate)beta1-3Galbeta1-4Xylbeta1-O-Ser and DeltaGlcUAbeta1-3GalNAc(6-O-sulfate)beta1-4GlcUAbeta1-3Galbeta1-3Gal(6-O-sulfate)beta1-4Xyl-ol. Identification of the reaction products obtained with the linkage tetra-, penta-, and hexasaccharide-serines revealed that the C6ST-1 catalyzed the sulfation of C6 on both galactose residues in the linkage region. Notably, the linkage tetrasaccharide-peptide GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-(Gly)Ser-(Gly-Glu) was a good acceptor substrate for the C6ST-1, suggesting that the sulfation of the galactose residues can occur before the transfer of the first N-acetylhexosamine residue to the linkage tetrasaccharide. In contrast, no incorporation was observed into DeltaGlcUAbeta1-3GalNAc(4-O-sulfate)beta1-4GlcUAbeta1-3Gal(4-O-sulfate)beta1-3Galbeta1-4Xyl-ol, indicating that an intact xylose is necessary for the transfer of a sulfate to the second sugar residue Gal from the reducing end. These findings clearly demonstrated that the recombinant C6ST-1 catalyzes the sulfation of C6 on both galactose residues in the linkage region in vitro. This is the first identification of the sulfotransferase responsible for the sulfation of galactose residues in the glycosaminoglycan-protein linkage region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697746     DOI: 10.1074/jbc.M803279200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  LC-MS/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications.

Authors:  Andrea Persson; Alejandro Gomez Toledo; Egor Vorontsov; Waqas Nasir; Daniel Willén; Fredrik Noborn; Ulf Ellervik; Katrin Mani; Jonas Nilsson; Göran Larson
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

2.  Development of a mouse monoclonal antibody against the chondroitin sulfate-protein linkage region derived from shark cartilage.

Authors:  Chizuru Akatsu; Duriya Fongmoon; Shuji Mizumoto; Jean-Claude Jacquinet; Prachya Kongtawelert; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2010-03-25       Impact factor: 2.916

Review 3.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

Review 4.  Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

Review 5.  An Overview of in vivo Functions of Chondroitin Sulfate and Dermatan Sulfate Revealed by Their Deficient Mice.

Authors:  Shuji Mizumoto; Shuhei Yamada
Journal:  Front Cell Dev Biol       Date:  2021-11-24

Review 6.  Determinants of Glycosaminoglycan (GAG) Structure.

Authors:  Kristian Prydz
Journal:  Biomolecules       Date:  2015-08-21

7.  Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease.

Authors:  Jian Lei; Huan Deng; Yan Ran; Yizhen Lv; Abebe Feyissa Amhare; Liyun Wang; Xiong Guo; Jing Han; Mikko J Lammi
Journal:  Cartilage       Date:  2020-06-09       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.